loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Cebranopadol

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Cebranopadol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903523518/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821421996/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805194778/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730108785/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol

    05 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230905720896/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share
    Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH'S Cebranopadol
    Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH'S Cebranopadol

    28 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230828282884/en

    BUSINESSWIRE
    28 Aug 2023
    Share Share